Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis.

CONCLUSIONS: Following a hospitalization for schizophrenia, PP1M treatment was associated with fewer 90-day rehospitalizations among young adults (18-35 years) relative to OAA treatment. This finding was also observed in other hospitalized adults with schizophrenia. PMID: 30106313 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30106313?dopt=Abstract

Source: Current Medical Research and Opinion - August 16, 2018 Category: Research Tags: Curr Med Res Opin Source Type: research